As of April 16, 2025, Collegium Pharmaceutical (COLL) has a market cap of $0.87 billion USD. According to our data, Collegium Pharmaceutical is ranked No.5231 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.87 B |
-5.69%
|
Dec 31, 2024 | $0.92 B |
-6.92%
|
Dec 29, 2023 | $0.99 B |
32.67%
|
Dec 30, 2022 | $0.75 B |
24.20%
|
Dec 31, 2021 | $0.60 B |
-6.74%
|
Dec 31, 2020 | $0.65 B |
-2.67%
|
Dec 31, 2019 | $0.66 B |
19.86%
|
Dec 31, 2018 | $0.55 B |
-6.99%
|
Dec 29, 2017 | $0.60 B |
18.56%
|
Dec 30, 2016 | $0.50 B |
-43.38%
|
Dec 31, 2015 | $0.89 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() Assertio Therapeutics
ASRT
|
$60.28 M |
-0.000 M
|
![]() USA
|
![]() Amneal Pharmaceuticals
AMRX
|
$3.34 B |
1.091 B
|
![]() USA
|
![]() Pacira Biosciences
PCRX
|
$1.15 B |
-0.000 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
Market Cap | = | COLL Stock Price | * | COLL Shares Outstanding |
= | $27.12 | * | 32.13 M | |
= | $0.87 B |